PK
Showing 26 - 50 of >10,000
Healthy Trial in Mahesana (Omalizumab 150mg)
Recruiting
- Healthy
- Omalizumab 150mg
-
Mahesana, Gujarat, IndiaRegistered BE centre
Nov 4, 2022
Healthy Trial in Shanghai (SR419 capsules, Placebo)
Completed
- Healthy
- SR419 capsules
- Placebo
-
Shanghai, ChinaShanghai Clinical Research Center Phase I Clinical Research Unit
Aug 2, 2022
Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab, Pembrolizumab biosimilar)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- Pembrolizumab
- Pembrolizumab biosimilar
- (no location specified)
Dec 19, 2022
Healthy Adult Subjects Trial in Christchurch (AVT05, Simponi)
Recruiting
- Healthy Adult Subjects
- AVT05
- Simponi
-
Christchurch, New ZealandNew Zealand Clinical Research
Jan 13, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B KAC
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022
PK of Piperacillin/Tazobactam in Adults Undergoing ECMO
Recruiting
- Acute Respiratory Failure With Hypoxia
-
New York, New YorkNewYork-Presbyterian Hospital
Jul 19, 2022
Healthy Trial in Shanghai (SR1375 capsules, Placebo)
Active, not recruiting
- Healthy
- SR1375 capsules
- Placebo
-
Shanghai, ChinaPhase I clinical laboratory of Huashan Hospital
Jul 14, 2022
Invasive Fungal Infections Trial (Rezafungin Acetate)
Not yet recruiting
- Invasive Fungal Infections
- Rezafungin Acetate
- (no location specified)
Sep 8, 2022
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Healthy Male Subjects Trial (AK104 (before the change), AK104 (after the change))
Not yet recruiting
- Healthy Male Subjects
- AK104 (before the change)
- AK104 (after the change)
- (no location specified)
Sep 26, 2022
AUD Trial in Changsha (Naltrexone implant, Placebo)
Recruiting
- AUD
- Naltrexone implant
- Placebo
-
Changsha, 湖南省, ChinaHunan Second People's Hospital
Jun 23, 2023
Cystinosis Trial (Cysteamine Bitartrate, N-Acetylcysteine Amide)
Not yet recruiting
- Cystinosis
- Cysteamine Bitartrate
- N-Acetylcysteine Amide
- (no location specified)
Aug 15, 2023
Autoimmune Diseases Trial in Christchurch (VIS171, Placebo)
Recruiting
- Autoimmune Diseases
- VIS171
- Placebo
-
Christchurch, New ZealandNew Zealand Clinical Research
Dec 6, 2022
Healthy Trial in Ahmedabad, Mahesana (ADL-018, US-licensed XOLAIR, EU-Approved XOLAIR)
Recruiting
- Healthy
- ADL-018
- +2 more
-
Ahmedabad, Gujarat, India
- +1 more
Sep 29, 2022
Healthy Volunteer Trial in San Antonio (DISC-0974, Placebo)
Completed
- Healthy Volunteer
- DISC-0974
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials
Jul 18, 2022
Post-menopausal Vasomotor Symptoms Trial in West Bend (ACER-801 50 mg BID, ACER-801 100 mg BID, ACER-801 200 mg BID)
Recruiting
- Post-menopausal Vasomotor Symptoms
- ACER-801 50 mg BID
- +3 more
-
West Bend, WisconsinSpaulding Clinical Research
Jan 30, 2023
Cannabis Trial in Netanya (THC/CBD S.E powder, THC/CBD oil)
Recruiting
- Cannabis
- THC/CBD S.E powder
- THC/CBD oil
-
Netanya, IsraelLaniado Hospital
Nov 27, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Teicoplanin in Intensive Care and Haematology Patients
Completed
- Bacterial Infections
- No intervention
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jan 30, 2023
Pharmacokinetics of Procaterol in Elite Athletes
Completed
- Asthma
-
Copenhagen, DenmarkBispebjerg Hospital
Feb 27, 2023